Panacea Index Logo

Command Palette

Search for a command to run...

Early versus late enteral prophylactic iron supplementation in preterm very low birth weight infants: a randomised controlled trial.

Archives of disease in childhood. Fetal and neonatal edition
March 1, 2014
Rojo Joy et al. (6 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

To determine whether early iron supplementation (2 mg/kg/day) at 2 weeks postnatal age improves serum ferritin levels compared to late supplementation at 6 weeks in preterm very low birth weight infants.

Results Summary

Early iron supplementation significantly increased serum ferritin and hemoglobin levels at 12 weeks compared to late supplementation, with no significant differences in neonatal morbidities, anthropometric parameters, or transfusion requirements between groups.

Population

Preterm very low birth weight (VLBW) infants in a tertiary care center in southern India.

Effective Dosage

2 mg/kg/day elemental iron

Duration

From 2 weeks to 12 weeks postnatal age

Interactions

None mentioned

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age
increase
serum ferritin level at 12 weeks
preterm very low birth weight (VLBW) infants
82±5 vs 63±3 ng/mL
significantly higher
#1
early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age
increase
haemoglobin at 12 weeks
preterm very low birth weight (VLBW) infants
10.1±0.4 vs 9.2±0.4 g/dL
significantly higher
#2
early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age
increase
mean corpuscular haemoglobin concentration at 12 weeks
preterm very low birth weight (VLBW) infants
31±0.5 vs 29.4±0.5 g/dL
significantly higher
#3
late iron (LI) supplementation at 6 weeks postnatal age
decrease
ferritin at 6 weeks compared with 2 weeks
preterm very low birth weight (VLBW) infants
-
significant decrease
#4
early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age
increase
ferritin at 6 weeks compared with 2 weeks
preterm very low birth weight (VLBW) infants
-
significant increase
#5
early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age
no change
incidences of neonatal morbidities (necrotising enterocolitis, periventricular leukomalacia, retinopathy of prematurity)
preterm very low birth weight (VLBW) infants
-
no significant differences
#6
early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age
no change
anthropometric parameters
preterm very low birth weight (VLBW) infants
-
no significant differences
#7
early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age
no change
blood transfusion requirements
preterm very low birth weight (VLBW) infants
-
no significant differences
#8
Abstract

OBJECTIVES: To evaluate whether preterm very low birth weight (VLBW) infants receiving early iron (EI) supplementation (2 mg/kg/day elemental iron) at 2 weeks postnatal age have improved serum ferritin levels compared with late iron (LI) supplementation at 6 weeks postnatal age. DESIGN: Single-blinded parallel-group interventional randomised controlled trial. SETTING: Tertiary care centre in southern India. INTERVENTIONS: Randomised at 2 weeks postnatal age to EI and LI groups and evaluated at 2, 6 and 12 weeks postnatal age. OUTCOME: The primary outcome was serum ferritin level at 12 weeks, and the secondary outcomes were the incidence of neonatal morbidities, haemoglobin level, anthropometric parameters and blood transfusion requirements. RESULTS: Of the 104 babies randomised, outcomes were analysed in 46 and 47 babies in EI and LI groups, respectively. Serum ferritin level was significantly higher (p<0.001) at 12 weeks (82±5 vs 63±3 ng/mL) in the EI group. Haemoglobin (10.1±0.4 vs 9.2±0.4 g/dL) and mean corpuscular haemoglobin concentration (31±0.5 vs 29.4±0.5 g/dL) were also significantly (p<0.001) higher at 12 weeks in the EI group. There was a significant decrease of ferritin in the LI group and significant increase in ferritin in the EI group at 6 weeks compared with 2 weeks. There were no significant differences in the incidences of neonatal morbidities (necrotising enterocolitis, periventricular leukomalacia, retinopathy of prematurity), anthropometric parameters and blood transfusion requirements between the two groups. CONCLUSIONS: EI supplementation in preterm VLBW infants improves serum ferritin and haemoglobin levels. TRIAL REGISTRATION: CTRI/2013/01/003277.

Medical Subject Headings (MeSH)
Anemia, Iron-DeficiencyBlood TransfusionC-Reactive ProteinDietary SupplementsDrug Administration ScheduleEnteral NutritionFemaleFerritinsHemoglobinsHumansImmunoassayInfantInfant, NewbornInfant, PrematureInfant, Premature, DiseasesInfant, Very Low Birth WeightIronMale
Study Links
Quality Scores
Safety85
Efficacy90/10
Quality80/10
Citation Metrics
Total Citations21
Citations/Year1.9
Relative Citation Ratio0.95
NIH Percentile48.4%
Research Impact Scores
APT Score0.75
Weight Score1.63
Normalized Score0.86
Related Supplements